Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III)

Craig I Coleman Hartford Hospital Division of Drug Information, Hartford, Connecticut, USA; Associate Professor Director, Cardiac Pharmacology Service, University of Connecticut Schools of Pharmacy, Storrs and Farmington, Connecticut, USA +1 860 545 2469; +1 860 545 2277; [email protected]

, PharmD,

Jeffrey Kluger Hartford Hospital Division of Cardiology, Hartford, Connecticut, USA; University of Connecticut Schools of Medicine, Storrs and Farmington, Connecticut, USA

, MD,

Krista Dale Hartford Hospital Division of Drug Information, Hartford, Connecticut, USA; Associate Professor Director, Cardiac Pharmacology Service, University of Connecticut Schools of Pharmacy, Storrs and Farmington, Connecticut, USA +1 860 545 2469; +1 860 545 2277; [email protected]

, PharmD BCPS,

Stephen Sander Hartford Hospital Division of Drug Information, Hartford, Connecticut, USA; Associate Professor Director, Cardiac Pharmacology Service, University of Connecticut Schools of Pharmacy, Storrs and Farmington, Connecticut, USA +1 860 545 2469; +1 860 545 2277; [email protected]

, PharmD,

Robert Gallagher Hartford Hospital Division of Surgery, Hartford, Connecticut, USA

, MD,

Kurt Reinhart Hartford Hospital Division of Drug Information, Hartford, Connecticut, USA; Associate Professor Director, Cardiac Pharmacology Service, University of Connecticut Schools of Pharmacy, Storrs and Farmington, Connecticut, USA +1 860 545 2469; +1 860 545 2277; [email protected]

, PharmD,

Nickole Henyan Hartford Hospital Division of Drug Information, Hartford, Connecticut, USA; Associate Professor Director, Cardiac Pharmacology Service, University of Connecticut Schools of Pharmacy, Storrs and Farmington, Connecticut, USA +1 860 545 2469; +1 860 545 2277; [email protected]

, PharmD &

C Michael White Hartford Hospital Division of Cardiology, Hartford, Connecticut, USA; Hartford Hospital Division of Drug Information, Hartford, Connecticut, USA; Associate Professor Director, Cardiac Pharmacology Service, University of Connecticut Schools of Pharmacy, Storrs and Farmington, Connecticut, USA +1 860 545 2469; +1 860 545 2277; [email protected]

, PharmD show all

Bibliography

Gillespie EL, Coleman CI, Sander S, et al. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann Pharmacother 2005;39:1409-15
PubMed Web of Science ®Google Scholar
Giri S, White CM, Dunn AB, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the atrial fibrillation suppression trial (AFIST). Lancet 2001;357:830-6
PubMed Web of Science ®Google Scholar
White CM, Caron MF, Kalus JS, et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the atrial fibrillation suppression trial II (AFIST II). Circulation 2003;108(Suppl II):II-200-6
Google Scholar
Hogue CW, Domitrovich PP, Stein Pk, et al. RR interval dynamic before atrial fibrillation in patients after coronary artery bypass graph surgery. Circulation 1998;98:429-34
PubMed Web of Science ®Google Scholar
White CM, Sander S, Coleman CI, et al. Impact of epicardial anterior fat pad retention on post-cardiothoracic surgery atrial fibrillation incidence: the atrial fibrillation suppression trial III (AFIST III). J Am Coll Cardiol 2007;49:298-303
PubMedGoogle Scholar
McKeowm PP, Gutterman D. Executive summery American college of chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005;128:S1-S5
Google Scholar
Coleman CI, Perkerson KA, Gillespie EL, et al. Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother 2004;38:2012-16
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III)

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III)

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date